Who
Yuichi Iwaki
President and CEO
Company insider
Files Form 4 as: President and CEO, MediciNova; Director, Avigen Inc \de.
In numbers
- Trades disclosed
- 116
- Buys
- 15
- Sells
- 6
- Bought
- $174K
- Sold
- $584K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 4 Jan 2006
- Last trade
- 16 Jan 2026
- Last filed
- 20 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jan 2026filed 20 Jan 2026 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 16 Jan 2026filed 20 Jan 2026 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,000 at $0.00 | filing |
| 12 Feb 2025filed 14 Feb 2025 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Jan 2025filed 10 Jan 2025 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —400,000 at $0.00 | filing |
| 9 Jan 2024filed 11 Jan 2024 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
| 23 Jan 2023filed 25 Jan 2023 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,125 at $0.00 | filing |
| 27 Jan 2022filed 31 Jan 2022 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —302,500 at $0.00 | filing |
| 9 Jul 2021filed 23 Jul 2021 | MNOV MediciNovaBiotechnology | SEC FORM 4 Code M | $101K39,583 at $2.54 | filing |
| 9 Jul 2021filed 23 Jul 2021 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code M | —39,583 at $0.00 | filing |
| 25 Feb 2021filed 1 Mar 2021 | MNOV MediciNovaBiotechnology | SEC FORM 4 Code M | $212K86,250 at $2.46 | filing |
| 25 Feb 2021filed 1 Mar 2021 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code M | —86,250 at $0.00 | filing |
| 2 Feb 2021filed 4 Feb 2021 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —495,000 at $0.00 | filing |
| 8 Apr 2020filed 13 Apr 2020 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code M | —60,417 at $0.00 | filing |
| 8 Apr 2020filed 13 Apr 2020 | MNOV MediciNovaBiotechnology | SEC FORM 4 Code M | $153K60,417 at $2.54 | filing |
| 12 Mar 2020filed 12 Mar 2020 | MNOV MediciNovaBiotechnology | SEC FORM 4 Bought | $62K20,000 at $3.10 | filing |
| 9 Jan 2020filed 10 Jan 2020 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —412,500 at $0.00 | filing |
| 15 Jan 2019filed 17 Jan 2019 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code A | —470,000 at $0.00 | filing |
| 3 Jan 2019filed 7 Jan 2019 | MNOV MediciNovaoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,572 at $0.00 | filing |
| 3 Jan 2019filed 7 Jan 2019 | MNOV MediciNovaBiotechnology | SEC FORM 4 Code M | $41K18,572 at $2.20 | filing |
| 5 Mar 2018filed 7 Mar 2018 | MNOV MediciNovaBiotechnology | SEC FORM 4 Code M | $110K50,003 at $2.20 | filing |
News
MediciNova (NASDAQ:MNOV) & Phibro Animal Health (NASDAQ:PAHC) Head to Head ComparisonMNOV · themarketsdaily.com · 14 Oct 2026MediciNova to Participate in the Maxim Growth SummitMNOV · manilatimes.net · 6 Oct 2026
0 headlines in the last 90 days name Yuichi Iwaki; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.